Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Juva Life Inc JUVAF

Juva Life Inc. is a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution. It is vertically integrated and consists of five divisions: Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, and Juva Retail. Juva Cultivation focuses on cultivating and distributing cannabis to medical and... see more

GREY:JUVAF - Post Discussion

Juva Life Inc > Arbitrage
View:
Post by Matteo1234 on Mar 01, 2022 5:51am

Arbitrage

Big boys stealing your shares in a illiquid stock. Stayhard...The news follows the Company’s identification of non-cannabinoid compound JUVA-019, on which the Company has filed a patent application and has conducted preclinical research showing that the compound is effective as a stand-alone compound in inhibiting inflammation by modulating certain biomarkers in the body. Through its research division, Juva scientists have continuously been evaluating an internally curated database of compounds found in the cannabis plant for their therapeutic benefit, leading to the identification of the two proprietary compounds: JUVA-019 and JUVA-041, which the Company has nominated as drug candidates for further pre-clinical investigation. Current efforts are focused on advancing both compounds through phenotypic models of chronic diseases of aging.
Comment by SpaceLabs on Mar 01, 2022 11:07am
Have you tried any of that to see if it works or not M1234? Seems like a HOAX by Doug Chlopeek. to raise more funds from Canadians again?
Comment by Richmond on Mar 08, 2022 5:16am
Chopolek will get shiitt for funds now. Canadians, don't get fooled but REPORT this crook to SEC and fet him arrested...
Comment by Matteo1234 on Mar 10, 2022 5:47am
More good news Pappy. Relax it's all good. Expand your time horizon. Stayhard.....Juva Life (JUVA) has announced the launch of the Journal App. The app is designed to help cannabis users and patients track their consumption and gain insight into how cannabis products affect their health and wellness. “We’re proud to be one of the first and only companies to offer consumers a daily tracking ...more  
Comment by Matteo1234 on Mar 11, 2022 1:40am
Wow bid and ask in the billions ? 
Comment by SpaceLabs on Mar 11, 2022 3:47pm
Ha Ha HAAAAAAA ! Mat Only a matter of time Doggy Dougy will DILUTE your shares into Stockton,CA,,,,, DIRT !
Comment by Richmond on Mar 08, 2022 5:13am
You have faith in the crooks who did PP at $1.05 and the share price is heading to .05c. Loss if $1.00 a share. ??????? The CROOKS of Juva collected $20M by FALSE .CLAIMS===== CRIMINALS.. LIARS....all rot in hell including Mackie and Co. Shiitts!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities